Image credit: Shutterstock

Image credit: Shutterstock

Quyi announced that it has secured US$40 million in Series B funding led by Baidu with participation from existing investors, HighLight Capital and SB China Capital.

The company received a US$8.5 million Series A round in September last year.

Founded in May 2015, Quyi is a developer of medical apps designed to shake up China’s medical sector. The Shanghai-based startup has developed three services that target core links in the industry.

Its flagship product Quyiyuan aims to improve a patient’s clinical experience by providing all kinds of related services from scheduling appointments, checking diagnosis reports, to making payments.

Also Read: Healthtech in Southeast Asia: Emerging trends and enduring realities

Quyi Hospital is a telemedicine system bringing together doctors to patients on mobile or in far-flung areas. The company is planning to roll out a new product to connect medical institutions and medical instrument manufacturers.

All of Quyi’s apps are constructed on the company’s comprehensive information platform, which is supported by patient data collected from Quyiyuan and has a deep integration with the systems of partner hospitals. The company claims to have more than 1000 public hospitals on board and expects the number to reach 2000 by the end of this year.

This tie-up will enable Quyi to gain more technical support from the Chinese Internet giant in terms of Big Data, web security and cloud technology.

Baidu has entered mobile heath industry with healthcare programme ‘Beijing Health Cloud’ and mobile app Baidu Doctor.

The article Baidu Injects $40 Million Into Mobile Health Startup Quyi first appeared on TechNode.